Lung diseases remain a critical public health challenge in Northern Nevada and are mostly related to issues concerning low ...

Researchers in China have developed a nomogram based on three CTPA-derived cardiac measurements that identifies group 1 ...

A new organoid model built with human lung fragments may help us answer key questions about one of the body's first lines of ...

Lung cancer kills more people worldwide than any other malignancy, and the reason is painfully simple: it is usually caught ...

Affinity Technologies receives Japanese patent for CyPath Lung test to detect lung cancer early: San Antonio Saturday, October 10, 2026, 13:00 Hrs [IST] bioAffinity Technologie ...

A new study suggests even brief e-cigarette use can cause lung distress and suppress the immune response to viral infections.

The number of ordering physicians increased by 89% in Q3 2026 compared to Q3 2025. Physicians who ordered CyPath Lung through Q3 2025 continued to expand utilization of the test, with sales volume ...

An estimated 70,000-100,000 people live with severe Alpha-1 in the U.S., but as many as 90% of these individuals haven't been ...

SAN ANTONIO, October 08, 2026--bioAffinity Technologies receives notice of allowance for new patent in Japan covering its noninvasive CyPath Lung diagnostic test for lung cancer.

Lakeland Regional Health opened its new Parkview location on Oct. 6 at 1409 N. Florida Ave.

Wearable-derived data provide new insights into how clinical outcomes for patients treated with CAVT and anticoagulation, and ...